Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KGC vs GSK✓SelectedUSD · GSKKGC vs GSK performance historyLatest closeAs of-5.10%11/20
Stock and ETF performance explorer

KGC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-28.1%
GSK return
+6.1%
Excess return
-34.2%
Maximum drawdown
-54.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.1%-0.1%-5.0%-5.1%
7D-16.4%-5.3%-11.1%-15.0%
30D-27.1%-3.7%-23.5%-26.4%
3M-44.8%-7.3%-37.5%-43.4%
6M-39.2%-4.2%-34.9%-38.4%
YTD-38.1%+0.9%-39.0%-33.5%
1Y-28.1%+7.3%-35.3%-22.0%
All-28.1%+6.1%-34.2%-22.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling